BackgroundVitiligo is a chronic disease characterized by the appearance of achromic
macules caused by melanocyte destruction. Surgical treatments with
melanocyte transplantation can be used for stable vitiligo cases. ObjectivesTo evaluate treatment response to the autologous transplantation of
noncultured epidermal cell suspension in patients with stable vitiligo.MethodsCase series study in patients with stable vitiligo submitted to noncultured
epidermal cell suspension transplantation and evaluated at least once,
between 3 and 6 months after the procedure, to observe repigmentation and
possible adverse effects. The maximum follow-up period for some patients was
24 months.ResultsOf the 20 patients who underwent 24 procedures, 25% showed an excellent rate
of repigmentation, 50% good repigmentation, 15% regular, and 10% poor
response. The best results were observed in face and neck lesions, while the
worst in extremity lesions (88% and 33% of satisfactory responses,
respectively). Patients with segmental vitiligo had a better response (84%)
compared to non-segmental ones (63%). As side effects were observed
hyperpigmentation of the treated area and the appearance of Koebner
phenomenon in the donor area.Study limitationsSome limitations of the study included the small number of patients, a
subjective evaluation, and the lack of long-term follow-up on the results.
CONCLUSION: Noncultured epidermal cell suspension transplantation is
efficient and well tolerated for stable vitiligo treatment, especially for
segmental vitiligo on the face and neck.